Quaternary ammonium-melphalan conjugate for anticancer therapy of chondrosarcoma: in vitro and in vivo preclinical studies

Author： Peyrode Caroline  

Publisher： Springer Publishing Company

ISSN： 0167-6997

Source： Investigational New Drugs, Vol.30, Iss.4, 2012-08, pp. : 1782-1790

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Synthesis, characterization and in vitro studies of pegylated melphalan conjugates

By Ajazuddin  

Drug Development and Industrial Pharmacy, Vol. 39, Iss. 7, 2013-07 ,pp. : 1053-1062

Informa Healthcare

Access to resources Recommend Favorite

Preclinical and clinical studies of anticancer drug-incorporated polymeric micelles

By Matsumura Yasuhiro  

Journal of Drug Targeting, Vol. 15, Iss. 7-8, 2007-08 ,pp. : 507-517

Informa Healthcare

Access to resources Recommend Favorite

Platinum Formulations as Anticancer Drugs Clinical and Pre-Clinical Studies

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 21, 2011-11 ,pp. : 2623-2631

Bentham Science Publishers

Access to resources Recommend Favorite

Quercetin-Decorated Curcumin Liposome Design for Cancer Therapy: In-Vitro and In-Vivo Studies

By  

Current Drug Delivery, Vol. 14, Iss. 8, 2017-12 ,pp. : 1053-1059

Bentham Science Publishers

Access to resources Recommend Favorite

EZN-2208 (PEG-SN38), A 40 kDa Polyethylene Glycol (PEG) Conjugate, As an Anticancer Agent: Review of Preclinical and Clinical Data

By  

Current Bioactive Compounds, Vol. 7, Iss. 1, 2011-01 ,pp. : 3-7

Bentham Science Publishers

Access to resources Recommend Favorite